Follow RSS for latest reports on this topicBreast Cancer - Market Research and Reports

Track and monitor developments in breast cancer research and commercial development. BioPortfolio markets and sells market research reports on breast cancer research and developments.

Breast cancer symptoms

Signs of breast cancer vary widely — from lumps to swelling to skin changes — and many breast cancers have no obvious symptoms at all. Symptoms that are similar to those of breast cancer may be the result of non-cancerous conditions like infection or a cyst.

Breast self-exam should be part of your monthly health care routine, and you should visit your doctor if you experience breast changes. If you're over 40 or at a high risk for the disease, you should also have an annual mammogram and physical exam by a doctor. The earlier breast cancer is found and diagnosed, the better your chances of beating it.

Breast cancer awareness - signs of breast cancer - see your medical practitioner if you notice any of the following:

  • a lump or area of thickened tissue in either breast
  • a change in the size or shape of one or both breasts
  • discharge from either of your nipples (which may be streaked with blood)
  • a lump or swelling in either of your armpits
  • dimpling on the skin of your breasts
  • a rash on or around your nipple
  • a change in the appearance of your nipple, such as becoming sunken into your breast
  • breast pain in either of your breasts or armpits not related to your period

Inflammatory breast cancer

Inflammatory breast cancer (IBC) is a rare and very aggressive disease in which cancer cells block lymph vessels in the skin of the breast. This type of breast cancer is called “inflammatory” because the breast often looks swollen and red, or “inflamed.”

Inflammatory breast cancer accounts for 1 to 5 percent of all breast cancers diagnosed in the United States. Most inflammatory breast cancers are invasive ductal carcinomas, which means they developed from cells that line the milk ducts of the breast and then spread beyond the ducts.

Inflammatory breast cancer progresses rapidly, often in a matter of weeks or months. Inflammatory breast cancer is either stage III or IV at diagnosis, depending on whether cancer cells have spread only to nearby lymph nodes or to other tissues as well.

Review the latest research on inflammatory breast cancer.

Triple negative breast cancer

If yout pathology report indicates that the breast cancer cells tested negative for estrogen receptors (ER-), progesterone receptors (PR-), and HER2 (HER2-) the cancer is triple-negative.

These negative results mean that the growth of the cancer is not supported by the hormones estrogen and progesterone, nor by the presence of too many HER2 receptors. Therefore, triple-negative breast cancer does not respond to hormonal therapy (such as tamoxifen or aromatase inhibitors) or therapies that target HER2 receptors, such as Herceptin (chemical name: trastuzumab). However, other medicines can be used to treat triple-negative breast cancer.

Review the latest research on triple-negative breast cancer.

Breast cancer stages

Extensive information can be found at: http://www.cancer.org/cancer/breastcancer/detailedguide/breast-cancer-staging

Research and Developmet

BioPortfolio provides extensive access to the latest strides against breast cancer, clinical trials, news, companies and research - please refer to the tabs above.

Breast cancer facts - UK

Breast cancer in the UK is diagnosed in nearly  46,000 people  each year, with just over 12,000 dying from breast cancer each year in he UK. There are several risk factors for developing breast cancer including age and a family history of the disease (BRAC2 gene mutation).

The type of cancer determines the treatment options, which have improved over the last decade or so;

Chemotherapy uses cytotoxic drugs to destroy breast cancer cells. It is known as a systemic treatment because the whole body is exposed to the drugs. This may be used in addition to surgery and/or radiotherapy, and it is usually given after surgery and before radiotherapy (adjuvant chemotherapy) or before surgery (neo-adjuvant chemotherapy or primary chemotherapy).

Hormone therapy may be used if your breast cancer is hormone receptor positive. Oestrogen receptor positive cancers make up around 75 per cent of breast cancers in post-menopausal women and around 50 to 60 per cent in pre-menopausal women. A hormone receptor test is now routinely carried out on tissue taken during a biopsy or after the operation to remove the breast cancer.

Radiotherapy uses high energy x-rays to destroy cancer cells, either before or after surgery. Surgery is usually the first treatment for breast cancer; either breast conserving surgery (lumpectomy or wide local excision) or a total mastectomy. Lymph nodes in the axilla be also be removed. Targeted therapies such as Herceptin (trastuzumab) are becoming more widely used, as they target the cancer cells directly, and there are clinical trials for many at the moment.

Breast Cancer Facts - USA

Definition of breast cancer: Cancer that forms in tissues of the breast. The most common type of breast cancer is ductal carcinoma, which begins in the lining of the milk ducts (thin tubes that carry milk from the lobules of the breast to the nipple). Another type of breast cancer is lobular carcinoma, which begins in the lobules (milk glands) of the breast. Invasive breast cancer is breast cancer that has spread from where it began in the breast ducts or lobules to surrounding normal tissue. Breast cancer occurs in both men and women, although male breast cancer is rare.

Estimated new cases and deaths from breast cancer in the United States in 2013:

New cases: 232,340 (female); 2,240 (male)
Deaths: 39,620 (female); 410 (male)

BioPortfolio's Easy Ordering System

  1. Search for the report you need from our store
  2. Make online payment with our easy checkout process
  3. Receive PDF report via email

Easy Online Payment or Pro Forma Invoice

We accept the following credit cards...



or can supply a pro-forma invoice if required.

Related Reports:

We found over 40 reports that matched your search.

Next 40 Matches >

Refine your search, and find more matches, using the form above.

Engineered T Cells Market by Type (Tumor Infiltrating Lymphocytes, T Cell Receptor, and Chimeric Antigen Receptor), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Leukemia, and Others), and End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023 [Report Updated: 01-01-2018]

T cell is a type of white blood cell, and plays an important role in cell-medicated immunity. Engineered T cells are genetically modified T cells, specifically altered for therapeutic actions against autoimmune diseases and various types of cancers. The engineered T cells are delivered into patient’s body to reduce toxicity levels and restrict antigen escape (inability of immune system to respon...Read More >>>

Published:
2018-01-01

Published by: Allied Market Research

Prices Starting From:
$3840

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022 [Report Updated: 01-08-2017]

“Global companion diagnostics market projected to grow at CAGR of 20.1%”The global companion diagnostics market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, a...Read More >>>

Published:
2017-08-01

Published by: MarketsandMarkets

Prices Starting From:
$5650

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]

Oncology Drugs market covers drugs that are used in the treatment of a wide range of cancer, sarcoma, and tumor. Some of the bestselling oncology drugs in 2016 include Avastin, Herceptin, Revlimid, MabThera/Rituxan, Gleevac/Glivec, Alimta, Zytiga, Tasigna, Sandostatin, and Afinitor.


The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>

Published:
2017-05-18

Published by: Allied Market Research

Prices Starting From:
$5370

Breast Pumps Market by Technology (Battery Powered Breast Pumps, Manual Breast Pumps and Electric Breast Pumps), Product Type (Closed System Breast Pumps and Open System Breast Pumps) and Application (Personal Use Pumps and Hospital/Healthcare Grade Pumps) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022 [Report Updated: 13-12-2016]

Breast pumps are medical devices used for extracting milk from the breast of lactating mother. These devices are used mainly by working women to continue breastfeeding while they are at work. In some cases, physicians also recommend breast pumps to stimulate milk supply when the baby is unable to latch-on and suckle. Breast pumps have emerged as a preferable choice for the working women. The marke...Read More >>>

Published:
2016-12-13

Published by: Allied Market Research

Prices Starting From:
$5370

Breast Imaging Technologies Market by Product [Ionizing Breast Imaging Technologies (Analog Mammography, Full-Field Digital Mammography (FFDM), 3D Breast Tomosynthesis Positron Emission Tomography/Computed Tomography (PET/CT), Molecular Breast Imaging/Breast-Specific Gamma Imaging (MBI/BSGI), Cone Beam Computed Tomography (CBCT), Positron Emission Mammography (PEM)); and Non-Ionizing Breast Imagin [Report Updated: 09-12-2016]

Breast imaging technologies are used for the early detection of breast-related disorders. These technologies are mainly used to detect breast cancer at its initial stages. Various imaging modalities such as mammography, MRI, and ultrasound facilitate in the screening and staging of breast cancer by identifying characteristic masses or calcifications in the breast tissue.nnThe global breast imaging...Read More >>>

Published:
2016-12-09

Published by: Allied Market Research

Prices Starting From:
$5370

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>

Published:
2016-12-01

Published by: Allied Market Research

Prices Starting From:
$5370

Published:
2016-09-15

Published by: MarketsandMarkets

Prices Starting From:
$5650

Breast Imaging Market: By Technology (Ionizing Technologies (Mammography, Digital, 3D Mammography, MBI, PET-CT, CBCT, PEM), Non-ionizing Technologies (Breast MRI, Breast Ultrasound, AWBU, Breast Thermography, Optical Imaging)) -Forecast (2016-2021) [Report Updated: 29-03-2016]

Breast imaging is a technology that is widely used to obtain a high resolution visualization of breast and related diseases. Breast cancer is the most common cancer found in women. Breast imaging techniques play a major role in early diagnosis of the disease by evaluating the advancement of the disease and deciding which treatment is suitable. This breast imaging technique enables doctors to obser...Read More >>>

Published:
2016-03-29

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2015-12-02

Published by: MarketsandMarkets

Prices Starting From:
$5650

Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others)-Forecast(2017-2022) [Report Updated: 18-07-2015]

Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save s...Read More >>>

Published:
2015-07-18

Published by: Industry ARC

Prices Starting From:
$5250

Published:
2015-06-10

Published by: MarketsandMarkets

Prices Starting From:
$5650

Additional Searches

You may also like to search separately for: Breast Cancer

We Stock...

{STICKYFOOTERMOBILE}